rosiglitazone Articles
Research shows diabetes drug rosiglitazone improves memory
21 November 2012
GlaxoSmithKline finalizes $3 billion deal with US government over marketing practices
4 November 2011
New twist in diabetes drugs could reduce life-threatening side effects
12 September 2011
GlaxoSmithKline below forecasts, as Avandia costs and demise pummel sales and lead to massive 4th-qtr 2010 loss
4 February 2011
GlaxoSmithKline 3rd-qtr 2010 profits weighed down by Avandia ban, flu vaccines and charges
22 October 2010
Impact of Avandia restrictions could benefit Januvia, Byetta and Victoza, US physician survey reveals
7 October 2010
Double whammy for GlaxoSmithKline, as European regulator suspends Avandia and US FDA further restricts use of the diabetes drug
24 September 2010
GlaxoSmithKline sells Croatian research center to Galapagos, names new CFO and enters supply deal with Lonza; EMEA update on Avandia and Pandemrix
9 September 2010
GlaxoSmithKline’s Avandia still available in UK, despite MHRA call for its suspension
7 September 2010
New study finds little difference in cardiac risk for GlaxoSmithKline’s Avandia and Takeda’s Actos
25 August 2010
GlaxoSmithKline gets negative NICE appraisal for Revolade; another attack on safety of Avandia
11 June 2010
US FDA approves Strativa’s Oravig, triggering a $20 million milestone for France’s BioAlliance; Agency could put hold on GSK
19 April 2010
Majority of researchers supporting GlaxoSmithKline’s Avandia “had ties to the firm;” Takeda pulls SR-Competact MAA
22 March 2010
GlaxoSmithKline responds to critical US Senate Finance Committee, defending safety of its Avandia
25 February 2010
AstraZeneca settles over transfer pricing in UK, agreeing to pay £505 million; GSK slumps on Avandia news
23 February 2010
GlaxoSmithKline “knew about heart attack risks of Avandia,” claim US Senators, who also slam FDA
22 February 2010
GlaxoSmithKline to refocus some research and seek efficiencies, despite posting huge 4th-qtr 2009 profits rise; applause from Science Minister
5 February 2010
GlaxoSmithKline beats forecasts with 3rd quarter2009 profits leaping 34%, despite generic competition
28 October 2009
FDA panel backs safety of B-MS/AZ' Onglyza
2 April 2009
Liraglutide combos see greater HbA1c drop
16 February 2009
Takeda and Lilly breach ABPI Code of Practice
8 December 2008
GSK reports lack of CV AEs in Avandia study
24 November 2008
Glycemic control data added to Avandia label
21 July 2008
UPDATE: FDA panel votes in favor of outcomes over surrogate markers in diabetes drug approval
7 July 2008
"Reassuring data" on Avandia CV outcomes
16 June 2008
Stock Commentary - Europe - week to April 7, 2008
14 April 2008
PDCO recommends PIPs for four drugs
3 March 2008
GSK sees 2008 EPS fall; posts 2007 results
18 February 2008
Japan stock market week to February 4 , 2008
14 February 2008
Stock Commentary - Europe - week to Feb 4, 2008
11 February 2008
GSK sees 4th-qtr profits fall, forecasts 2008 EPS decline
11 February 2008
Stock Commentary - Europe - week to Jan 28, 2008
4 February 2008
EMEA seeks expanded rosiglitazone warning
4 February 2008
US Rep opposes FDA foundation member
24 December 2007
GSK defends Avandia against findings of CV risk by ICES group
17 December 2007
Japan stock market week to Nov 26, 2007
3 December 2007
Stock Commentary - Europe - week to Nov 19
26 November 2007
GSK buys heart drug specialist for $1.65B
26 November 2007
Takeda ads to promote Actos' lack of cardio risks
26 November 2007
Japan stock market week to Nov 12, 2007
19 November 2007
FDA orders GSK to add warning to Avandia
19 November 2007
Avandia withdrawals increase and accelerate; TNS report
19 November 2007
Stock Commentary - Europe - week to Oct 29, 2007
5 November 2007
Japan stock market week to Oct 29, 2007
5 November 2007
EMEA: Avandia/Actos benefits outweigh risks
29 October 2007
GSK boss defends OTC business
17 September 2007
Latest JAMA findings slam Avandia CV safety
17 September 2007
Japan stock market week to August 27, 2007
3 September 2007
TZD diabetes drugs to get black box warning
20 August 2007
Stock Commentary - Europe - week to August 6, 2007
13 August 2007
Stock Commentary - New York week to July 30, 2007
6 August 2007
Stock Commentary - Europe - week to July 30, 2007
6 August 2007
Japan stock market week to July 2, 2007
9 July 2007
Avandia dominates debate at ADA conference
2 July 2007
US scripts of GSK's Avandia continue to fall
2 July 2007
Texas family is first to sue GSK over Avandia
25 June 2007
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
